Tazarotene
A prescription retinoid prodrug selective for RAR-β and RAR-γ. Stronger anti-acne and anti-psoriasis efficacy than tretinoin.
Converted to tazarotenic acid, which binds RAR-β/γ with high selectivity, normalising keratinisation.
- Most potent topical retinoid
- Effective for psoriasis
- Anti-acne
- Anti-photoaging
What the evidence supports.
- All skin types
- Pregnant
- Breastfeeding
Later treatment or moisturiser step.
Concentration range in well-formulated products: 0.05%–0.1%
Year-round under MD; reinforce barrier and SPF.
Buffer with moisturiser pre + post; expect significant retinisation in first 4 weeks.
Tazarotene is a regulated medication. Use only under the guidance of a licensed physician or dermatologist. The information here is educational, Skinlumis does not dispense prescriptions or provide medical advice.
The research behind Tazarotene.
Every claim on this page traces to published research. Findings below are drawn from randomized trials and systematic reviews, each links to the study on PubMed.
American Journal of Clinical Dermatology, 2020
Journal of Cutaneous Medicine and Surgery, 2020
Journal of Advanced Research, 2015
Dermato-Endocrinology, 2011
Sign up to see how Tazarotene fits your skin archetype and personalised protocol.